StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Earnings

Invivyd's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$14.30M
+21.2% on a year earlier
EPS, Q2 FY2026
-$0.14
-$0.12 a year earlier
Latest guidance
Reaffirmed
Aug 14, 2024 · 1 item

Quarterly results

Revenue and earnings per share from each of Invivyd's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 13, 2026during market hours$14.30M+21.2%-$0.14Release
Q1 FY2026ended Mar 31, 2026May 14, 2026before the open$13.70M–-$0.13Release
Q4 FY2025ended Dec 31, 2025Mar 5, 2026before the open$17.20M––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025before the open$13.10M+40.9%-$0.06Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours$11.80M+413.0%-$0.12Release
Q1 FY2025ended Mar 31, 2025May 15, 2025before the open––-$0.14Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024before the open$9.30M–-$0.51Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024before the open$2.30M–-$0.40Release
Q1 FY2024ended Mar 31, 2024May 9, 2024during market hours––-$0.38Release
Q4 FY2023ended Dec 31, 2023Mar 28, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Invivyd guided for has been reported

Guidance history

Every forecast Invivyd put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 14, 2024net product revenueFY2024$150.00M – $200.00MReaffirmed
May 9, 2024net product revenueFY2024$150.00M – $200.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Invivyd filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. News
  5. Results
  6. News
  7. Results
  8. Results
  9. News
  10. News
  11. Results
  12. Results
  13. Results
  14. Results
  15. News

See a number that looks wrong?